Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy

Posted on 11/15/2025
59:42 |

Featuring perspectives from Dr Jeremy S Abramson and Dr Manali Kamdar, including the following topics:

  • Introduction: About This Program (0:00)
  • Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (3:10)
  • Potential Treatment Benefits of CAR T-Cell Therapy (10:35)
  • CRS (Cytokine Release Syndrome) and ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome) (34:32)
  • Finding Information About CAR T; Clinical Trials (42:17)
  • Financial Issues; Risk of Infection (48:11)
  • Coping with Anxiety; Healing and Moving On (55:17)

Educational and presenter information